Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
Zhang, Ling; Zeng, Xiaoxi; Fu, Ping; Wu, Hong Mei.
Cochrane Database Syst Rev
; (6): CD009120, 2014 Jun 23.
Artigo em Inglês | MEDLINE | ID: mdl-24953826
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
Aldosterone antagonists for preventing the progression of chronic kidney disease.
Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: A meta-analysis of randomized controlled trialsâ©.
Interventions for renal vasculitis in adults.
Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
The impact of residual renal function on quality of life in patients with peritoneal dialysisâ©.
Antihypertensive agents for preventing diabetic kidney disease.
Pharmacological interventions for hypertension in children.
Non-immunosuppressive treatment for IgA nephropathy.